RTCIT – AB
Fast-Acting Antimalarial Injection for Critical Care
RTCIT-AB Injection is a high-quality Arteether 150 mg/2 ml injectable formulation manufactured by Citric Labs for the effective treatment of acute uncomplicated and severe Plasmodium falciparum malaria. Arteether belongs to the artemisinin class of antimalarial medicines and acts rapidly by reducing the parasite load in the bloodstream, making it an important treatment option when prescribed by healthcare professionals. Arteether injection is administered intramuscularly under medical supervision and is intended for hospital or clinical use only.
Composition
- Arteether 150 mg
Key Benefits
- Fast-acting antimalarial therapy
- Effective against Plasmodium falciparum malaria
- Suitable for chloroquine-resistant malaria cases
- High-quality injectable formulation
- Manufactured in quality-controlled facilities
- Reliable product for hospitals and healthcare institutions
Product Description
RTCIT-AB Injection contains Arteether 150 mg/2 ml, a fast-acting antimalarial injection used for the treatment of Plasmodium falciparum malaria, including chloroquine-resistant cases, under medical supervision. Citric Labs offers premium-quality Arteether Injection for PCD Pharma Franchise and Third-Party Manufacturing across India.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
